Rothschild Investment LLC Dyne Therapeutics, Inc. Transaction History
Rothschild Investment LLC
- $1.44 Trillion
- Q2 2024
A detailed history of Rothschild Investment LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 35 shares of DYN stock, worth $1,274. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35Holding current value
$1,274% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
201Shares Held
106MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$292 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$286 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$269 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$233 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$220 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.88B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...